Low Risk of Severe Hypoglycaemia in Patients With Type 2 Diabetes Mellitus Starting Insulin Therapy With Premixed Insulin Analogues Bid in Outpatient Settings
Yükleniyor...
Dosyalar
Tarih
2012
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Wıley
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Aims: The choice of insulin at initiation in type 2 diabetes remains controversial. The aim of this study was to assess the occurrence of self-reported severe hypoglycaemia associated with premixed insulin analogues in routine clinical care. Methods: A 12-month, prospective, observational, multicentre study in patients starting a commonly prescribed premixed insulin analogue (either insulin lispro 25/75 or biphasic insulin aspart 30/70, twice daily) after suboptimal glycaemic control on oral antidiabetic agents. Treatment decisions were made solely in the course of usual practice. Results: Study follow-up was completed by 991 (85.5%) of the 1150 patients enrolled. At baseline, mean (SD) age was 57.9 (10.1) years; mean diabetes duration was 9.2 (5.9) years; mean haemoglobin A1c (HbA1c) was 9.9 (1.8) % and the rate of severe hypoglycaemia was 0.03 episode/patient-year. At 12 months, the rate of severe hypoglycaemia was 0.04 episode/patient-year (95% CI 0.023, 0.055 episode/patient-year) and mean insulin dose was 41.5 (19.4) units. Changes from baseline to 12 months for mean fasting plasma glucose and HbA1c were -5.1 mmol/l and -2.5%, respectively. Conclusions: After initiation of premixed insulin analogues in patients with type 2 diabetes in real-world settings, the incidence of severe hypoglycaemia was lower than expected from previously reported studies.
Açıklama
Anahtar Kelimeler
Kaynak
International Journal of Clinical Practice
WoS Q Değeri
Q1
Scopus Q Değeri
Q2
Cilt
66
Sayı
11
Künye
Pirags, V., El Damassy, H., Dabrowski, M., Gonen, M. S., Racicka, E., Martinka, E., Giaconia, J., Stefanski A., (2012). Low Risk of Severe Hypoglycaemia in Patients With Type 2 Diabetes Mellitus Starting Insulin Therapy With Premixed Insulin Analogues Bid in Outpatient Settings. International Journal of Clinical Practice, 66(11), 1033-1041. Doi: 10.1111/j.1742 1241.2012.03001.x
